GT Biopharma, Inc. reports

Company location: San Francisco, CA
Fiscal year end: 31 December

GT Biopharma, Inc. has filed 868 SEC EDGAR filings since 12 May 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-20 of 20 matching filings.

Per page

Current page

10-K File 001-40023

10-K

Filing date: 02 Mar 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 001-40023

10-K/A filing

Filing date: 14 Apr 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40023

10-K filing

Filing date: 21 Feb 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40023

10-K filing

Filing date: 26 Mar 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40023

10-K filing

Filing date: 30 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40023

10-K filing

Filing date: 28 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40023

ANNUAL REPORT

Filing date: 16 Apr 2021
Reporting date: 31 Dec 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

ANNUAL REPORT

Filing date: 27 Mar 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

ANNUAL REPORT

Filing date: 29 Mar 2019
Reporting date: 31 Dec 2018
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

ANNUAL REPORT

Filing date: 01 Mar 2018
Reporting date: 31 Dec 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 000-08092

FORM 10-K/A

Filing date: 28 Feb 2018
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 000-08092

FORM 10-K/A

Filing date: 28 Feb 2018
Reporting date: 31 Dec 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

ANNUAL REPORT

Filing date: 31 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

ANNUAL REPORT

Filing date: 30 Mar 2016
Reporting date: 31 Dec 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

OXIS INTERNATIONAL ANNUAL REPORT 2014

Filing date: 31 Mar 2015
Reporting date: 31 Dec 2014
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

OXIS INTERNATIONAL ANNUAL REPORT

Filing date: 08 Jan 2015
Reporting date: 31 Dec 2013
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

OXIS INTERNATIONAL, INC. ANNUAL REPORT 2012

Filing date: 18 Nov 2014
Reporting date: 31 Dec 2012
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

OXIS ANNUAL REPORT 2011

Filing date: 16 Apr 2012
Reporting date: 31 Dec 2011
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-08092

OXIS INTERNATIONAL 2010 ANNUAL REPORT

Filing date: 31 Mar 2011
Reporting date: 31 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-08092

OXIS ANNUAL REPORT 2009

Filing date: 30 Mar 2010
Reporting date: 31 Dec 2009
SEC evidence: Open document Open filing
Next action: Verify source filing